Quanterix Corporation Other Noncash Income (Expense)
Quanterix Corporation (QTRX) reported Other Noncash Income (Expense) of $558.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-10
- Quanterix Corporation other noncash income (expense) for the quarter ending 2026-06-30 was $573.00K.
- Quanterix Corporation other noncash income (expense) for the quarter ending 2026-03-31 was -$15.00K, a 103.64% decline year-over-year.
- Quanterix Corporation other noncash income (expense) for the quarter ending 2025-12-31 was $464.00K.
- Quanterix Corporation other noncash income (expense) for the quarter ending 2025-09-30 was -$294.00K, a 178.19% decline year-over-year.
- Quanterix Corporation other noncash income (expense) for fiscal 2025 was $540.00K.
- Quanterix Corporation other noncash income (expense) for fiscal 2024 was -$345.00K.
- Quanterix Corporation other noncash income (expense) for fiscal 2023 was -$140.00K, a 141.18% decline from fiscal 2022.
- Quanterix Corporation other noncash income (expense) for fiscal 2022 was $340.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $573.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $558.00K 10-Q · filed 2026-08-10 | $1.02M derived: sum of 3 quarters · filed 2026-08-10 | $728.00K derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2026-03-31 | -$15.00K 10-Q · filed 2026-05-06 | $449.00K derived: sum of 2 quarters · filed 2026-05-06 | $155.00K derived: sum of 3 quarters · filed 2026-05-06 | $113.00K derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-12-31 | $464.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $170.00K derived: sum of 2 quarters · filed 2026-03-02 | $128.00K derived: sum of 3 quarters · filed 2026-08-10 | $540.00K 10-K · filed 2026-03-02 | ||
| 2025-09-30 | -$294.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$336.00K derived: sum of 2 quarters · filed 2026-08-10 | $76.00K 10-Q · filed 2025-11-10 | -$658.00K derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-06-30 | -$42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $370.00K 10-Q · filed 2026-08-10 | -$364.00K derived: sum of 3 quarters · filed 2026-08-10 | $12.00K derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-03-31 | $412.00K 10-Q · filed 2026-05-06 | -$322.00K derived: sum of 2 quarters · filed 2026-05-06 | $54.00K derived: sum of 3 quarters · filed 2026-05-06 | $122.00K derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | -$734.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$358.00K derived: sum of 2 quarters · filed 2026-03-02 | -$290.00K derived: sum of 3 quarters · filed 2026-03-02 | -$345.00K 10-K · filed 2026-03-02 | -$55.00K 10-K · filed 2025-03-17 | |
| 2024-09-30 | $376.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $444.00K derived: sum of 2 quarters · filed 2025-11-10 | $389.00K 10-Q · filed 2025-11-10 | $896.00K derived: sum of 4 quarters · filed 2026-03-02 | ||
| 2024-06-30 | $68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $13.00K 10-Q · filed 2025-08-07 | $520.00K derived: sum of 3 quarters · filed 2026-03-02 | $475.00K derived: sum of 4 quarters · filed 2026-03-02 | ||
| 2024-03-31 | -$55.00K 10-Q · filed 2025-05-12 | $452.00K derived: sum of 2 quarters · filed 2026-03-02 | $407.00K derived: sum of 3 quarters · filed 2026-03-02 | $75.00K derived: sum of 4 quarters · filed 2026-03-02 | ||
| 2023-12-31 | $507.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $462.00K derived: sum of 2 quarters · filed 2026-03-02 | $130.00K derived: sum of 3 quarters · filed 2026-03-02 | -$140.00K 10-K · filed 2026-03-02 | -$150.00K 10-K · filed 2024-02-29 | |
| 2023-09-30 | -$45.00K derived: 10-Q 9 month − 10-K/A 6 month · filed 2024-12-26 | -$377.00K derived: sum of 2 quarters · filed 2024-12-26 | -$647.00K 10-Q · filed 2024-12-26 | |||
| 2023-06-30 | -$332.00K derived: 10-K/A 6 month − 10-Q/A 3 month · filed 2024-12-26 | -$602.00K 10-K/A · filed 2024-12-26 | -$548.00K 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | -$270.00K 10-Q/A · filed 2024-12-26 | |||||
| 2022-12-31 | $340.00K 10-K · filed 2025-03-17 | $439.00K 10-K · filed 2024-02-29 | ||||
| 2021-12-31 | -$692.00K 10-K/A · filed 2024-12-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |